StonvexLoading…
StonvexStonvexStonvexCore line items from SEPN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $45.95M | $1.07M | $151.00K |
Operating Income | $-68.30M | $-80.82M | $2.08M |
Net Income | $-48.88M | $-71.80M | $4.18M |
EPS (Diluted) | $-1.10 | $-7.26 | $0.29 |
Total Assets | $596.19M | $456.55M | $130.87M |
Total Liabilities | $214.26M | $36.51M | $20.03M |
Cash & Equivalents | $120.72M | $238.20M | $88.48M |
Free Cash Flow OCF − CapEx | $109.67M | $-69.57M | $-41.60M |
Shares Outstanding | 44.81M | 44.42M | 3.17M |